Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...

The GLP-1 drugs continue to make headlines due to their FDA-approved uses for treating Type 2 diabetes and obesity, but a ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.

Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...

It is possible to mimic the effect of GLP-1 in the body to boost weight loss with the right kind of diet. Read weight loss ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

SHOPPING: Achieve your weight goals in 2025 with help from this potent polyphenol blend that boosts your natural production ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...